Also known as Zolinza
Vorinostat (rINN) or suberoylanilide hydroxamic acid (SAHA) is a member of a larger class of compounds that inhibit histone deacetylases (HDAC). Histone deacetylase inhibitors (HDI) have a broad spectrum of epigenetic activities.Source: Wikipedia
Estimated Total Cost: $6403.8 for an average of 28 days supply
Patients are most commonly prescribed vorinostat to treat blastomycosis, rabies, west nile virus, and pick disease.
Patients taking vorinostat most commonly experience side effects like diarrhea, fatigue, and nausea.